Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00560898 · ClinicalTrials.gov registry record · Phase 4
Comparison of Two Multi-Purpose Solution and Lens Material Combinations on Corneal Barrier Function
A Phase 4 study, sponsored by Southern California College of Optometry at Marshall B. Ketchum University.
- Completed
- Registry status
- Phase 4
- Development phase
- 25
- Enrollment target
NCT00560898: Completed Phase 4 study, sponsored by Southern California College of Optometry at Marshall B. Ketchum University.
NCT00560898 is a Phase 4 study that has completed, run by Southern California College of Optometry at Marshall B. Ketchum University. The registered enrollment target is 25 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00560898, a Phase 4 study, has completed, sponsored by Southern California College of Optometry at Marshall B. Ketchum University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to measure the relative "barrier" function of the top layer of the cornea (called the epithelium), or the degree to which the cornea can prevent the penetration of the colored dye sodium fluorescein into the eye. This is a clinical investigation of the effect on corneal barrier function following wear of two contact lens materials and two contact lens care systems, approved for marketing in the US by the Food and Drug Administration. These contact lenses will be worn for two hours, following soak in one of two marketed contact lens disinfecting solutions. Approximately 25 young, adapted contact lens wearers will participate.
Interventions
- DRUG ProClear Lens Material soaked in ReNu Multiplus Multipurpose Solution
- DRUG Acuvue Advance Lens Material soaked in ReNu Multiplus Multipurpose Solution
- DRUG Acuvue Advance Lens Material soaked in Optifree RepleniSH Multipurpose Solution
- DRUG ProClear Lens Material soaked in Optifree RepleniSH Multipurpose Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2007-09 |
| Est. Completion | 2008-03 |
| Phase | Phase 4 |
What the finished NCT00560898 record still lists
NCT00560898 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 4 interventions - of which ProClear Lens Material soaked in ReNu Multiplus Multipurpose Solution is the first listed.
NCT00560898 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00560898 about?
NCT00560898 is a clinical study titled "Comparison of Two Multi-Purpose Solution and Lens Material Combinations on Corneal Barrier Function". The purpose of this study is to measure the relative "barrier" function of the top layer of the cornea (called the epithelium), or the degree to which the cornea can prevent the penetration of the colored dye sodium fluorescein into the eye. This is a clinical investigation of the effect on corneal ...
What is the current status of trial NCT00560898?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 25 participants. The study started on 2007-09. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00560898?
The interventions under investigation include: ProClear Lens Material soaked in ReNu Multiplus Multipurpose Solution (DRUG), Acuvue Advance Lens Material soaked in ReNu Multiplus Multipurpose Solution (DRUG), Acuvue Advance Lens Material soaked in Optifree RepleniSH Multipurpose Solution (DRUG), ProClear Lens Material soaked in Optifree RepleniSH Multipurpose Solution (DRUG).
Who is sponsoring clinical trial NCT00560898?
This trial is sponsored by Southern California College of Optometry at Marshall B. Ketchum University, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00560898's enrollment target sits among peer trials
25 1669th of 2000 higher than 302 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia